Income Statement InterCure Ltd.

Stocks

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 07:54:38 22/07/2026 pm IST			5-day change	1st Jan Change
288.50 ^ILa	+2.30%		-3.45%	-10.85%

22/06	InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
15/06	InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition	MT

d5f88c401c4a61362.UBAHwU2YiWbAIFdqtjJKUUoKqGqzeNUx9MZAd4hoCNI.fUdLmwnT6BCOSBE1-0MkCH9wzQPEFrcEvaM4A808W78SYTWWAMf9EvVtMA

Published financial data: INTERCURE LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Revenues	22Cr	39Cr	36Cr	24Cr	27Cr
Total Revenues	22Cr	39Cr	36Cr	24Cr	27Cr
Cost of Goods Sold, Total	12Cr	22Cr	25Cr	20Cr	23Cr
Gross Profit	10Cr	17Cr	11Cr	4.21Cr	4.07Cr
Selling General & Admin Expenses, Total	5.04Cr	9.26Cr	9.59Cr	11Cr	9.34Cr
Stock-Based Compensation (IS)	64.52L	89.07L	25.92L	22.81L	24.29L
R&D Expenses	12.35L	6L	4L	4L	4L
Other Operating Expenses	1.4Cr	2.9Cr	1.12Cr	1.94Cr	1.17Cr
Other Operating Expenses, Total	7.22Cr	13Cr	11Cr	13Cr	11Cr
Operating Income	3.04Cr	4.09Cr	-15.03L	-8.79Cr	-6.72Cr
Interest Expense, Total	-4L	-6L	-7L	-2.06Cr	-1.97Cr
Interest And Investment Income	1L	8L	53.75L	27L	15.55L
Net Interest Expenses	-3L	2L	46.49L	-1.79Cr	-1.81Cr
Income (Loss) On Equity Invest.	-	-	-	-	3L
Currency Exchange Gains (Loss)	-45.36L	73.26L	-46T	-23T	14.19L
Other Non Operating Income (Expenses)	-46.27L	-1.43Cr	-2.43Cr	-21.47L	-2L
EBT, Excl. Unusual Items	2.1Cr	3.41Cr	-2.12Cr	-11Cr	-8.38Cr
Merger & Related Restructuring Charges	-4L	-6L	-4L	-	-
Impairment of Goodwill	-	-	-6.31Cr	-	-
Gain (Loss) On Sale Of Investments	-18.68L	-2L	-29.95L	-1.22Cr	-3.01Cr
Asset Writedown	-	-	-45.89L	-	-
Other Unusual Items	-	1.06Cr	3.1Cr	3.29Cr	6.98Cr
EBT, Incl. Unusual Items	1.87Cr	4.38Cr	-6.13Cr	-8.73Cr	-4.41Cr
Income Tax Expense	1.14Cr	93T	22.48L	-1.45Cr	-73.19L
Earnings From Continuing Operations	72.95L	4.37Cr	-6.35Cr	-7.28Cr	-3.68Cr
Net Income to Company	72.95L	4.37Cr	-6.35Cr	-7.28Cr	-3.68Cr
Minority Interest	-26.03L	10.7L	15.74L	49.98L	10.74L
Net Income - (IS)	46.92L	4.48Cr	-6.2Cr	-6.78Cr	-3.57Cr
Net Income to Common Incl Extra Items	46.92L	4.48Cr	-6.2Cr	-6.78Cr	-3.57Cr
Net Income to Common Excl. Extra Items	46.92L	4.48Cr	-6.2Cr	-6.78Cr	-3.57Cr
Per Share Items
Net EPS - Basic	0.12	0.99	-1.36	-1.48	-0.66
Basic EPS - Continuing Operations	0.12	0.99	-1.36	-1.48	-0.66
Basic Weighted Average Shares Outstanding	3.85Cr	4.54Cr	4.56Cr	4.59Cr	5.37Cr
Net EPS - Diluted	0.1	0.99	-1.36	-1.48	-0.66
Diluted EPS - Continuing Operations	0.1	0.99	-1.36	-1.48	-0.66
Diluted Weighted Average Shares Outstanding	4.89Cr	4.54Cr	4.56Cr	4.59Cr	5.37Cr
Normalized Basic EPS	0.27	0.49	-0.26	-1.36	-0.95
Normalized Diluted EPS	0.21	0.49	-0.26	-1.36	-0.95
Supplemental Items
EBITDA	3.55Cr	4.83Cr	66.81L	-7.82Cr	-5.53Cr
EBITA	3.04Cr	4.09Cr	-15.03L	-8.79Cr	-6.72Cr
EBIT	3.04Cr	4.09Cr	-15.03L	-8.79Cr	-6.72Cr
EBITDAR	3.81Cr	4.93Cr	80.11L	-7.71Cr	-5.46Cr
Effective Tax Rate - (Ratio)	61.06	0.21	-3.67	16.64	16.6
Total Current Taxes	94.99L	1.77Cr	62.94L	-8L	3L
Total Deferred Taxes	19.42L	-1.76Cr	-40.46L	-1.37Cr	-76.24L
Normalized Net Income	1.05Cr	2.24Cr	-1.17Cr	-6.25Cr	-5.13Cr
Interest on Long-Term Debt	5L	7L	7L	8L	8L
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.32Cr	5.65Cr	5.33Cr	5.42Cr	5.25Cr
General and Administrative Expenses	2.72Cr	3.61Cr	4.26Cr	5.37Cr	4.09Cr
Research And Development Expense From Footnotes	12.35L	6L	4L	4L	4L
Net Rental Expense, Total	25.74L	10L	13.3L	11.52L	8L
Imputed Operating Lease Interest Expense	1L	27.35T	34.26T	9L	6L
Imputed Operating Lease Depreciation	24.24L	10L	12.96L	2L	2L
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	64.52L	89.07L	25.92L	22.81L	24.29L
Total Stock-Based Compensation	64.52L	89.07L	25.92L	22.81L	24.29L

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Assets
Cash And Equivalents	20Cr	23Cr	10Cr	7.83Cr	4.65Cr
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	3L	2L	2L	3L	2L
Total Cash And Short Term Investments	20Cr	23Cr	10Cr	7.87Cr	4.67Cr
Accounts Receivable, Total	1.86Cr	4.08Cr	6.11Cr	5.25Cr	2.18Cr
Other Receivables	1.43Cr	2.48Cr	6.91Cr	8.72Cr	13Cr
Notes Receivable	46.8L	6.44Cr	4.05Cr	4.09Cr	61.69L
Total Receivables	3.75Cr	13Cr	17Cr	18Cr	15Cr
Inventory	6.23Cr	12Cr	11Cr	12Cr	11Cr
Prepaid Expenses	49.79L	31.32L	12.85L	15.07L	11.37L
Restricted Cash	2.11Cr	1.39Cr	96.6L	13.16L	20.34L
Other Current Assets, Total	1.37Cr	75.77L	3.03Cr	95.24L	44.23L
Total Current Assets	34Cr	51Cr	42Cr	39Cr	32Cr
Gross Property Plant And Equipment	9.8Cr	13Cr	14Cr	16Cr	17Cr
Accumulated Depreciation	-1.15Cr	-2.32Cr	-4.02Cr	-5.45Cr	-7.15Cr
Net Property Plant And Equipment	8.65Cr	10Cr	9.75Cr	11Cr	10Cr
Long-term Investments	25.65L	2.26Cr	19.22L	21.47L	10.23L
Goodwill	26Cr	28Cr	22Cr	22Cr	22Cr
Loans Receivable Long-Term	-	2Cr	1.84Cr	-	-
Deferred Tax Assets Long-Term	30.2L	2.06Cr	2.47Cr	3.84Cr	4.6Cr
Other Long-Term Assets, Total	1T	-	42.07L	4L	47.9L
Total Assets	69Cr	96Cr	79Cr	76Cr	69Cr
Liabilities
Accounts Payable, Total	6.45Cr	13Cr	7.84Cr	7.75Cr	6.81Cr
Accrued Expenses, Total	59.59L	1.06Cr	1.25Cr	1.43Cr	1.73Cr
Short-term Borrowings	17.22L	10.9L	-	-	1.1Cr
Current Portion of Long-Term Debt	7.06Cr	13Cr	8.82Cr	6.94Cr	8.88Cr
Current Portion of Leases	33.07L	43.49L	46.4L	47.89L	42.62L
Unearned Revenue Current, Total	29.01L	80.6L	-	-	-
Other Current Liabilities	4.47Cr	3.56Cr	4.21Cr	6.06Cr	2.49Cr
Total Current Liabilities	19Cr	31Cr	23Cr	23Cr	21Cr
Long-Term Debt	1.2Cr	9.97Cr	8.22Cr	11Cr	5.95Cr
Long-Term Leases	2.14Cr	2.31Cr	2.06Cr	2.32Cr	1.95Cr
Pension & Other Post Retirement Benefits	2L	10.25L	8L	10L	9L
Other Non Current Liabilities	-1T	-	-	-	-
Total Liabilities	23Cr	44Cr	33Cr	36Cr	29Cr
Common Stock, Total	62Cr	63Cr	64Cr	66Cr	68Cr
Retained Earnings	-19Cr	-14Cr	-20Cr	-28Cr	-31Cr
Comprehensive Income and Other	1.09Cr	1.09Cr	1.59Cr	1.59Cr	3.55Cr
Total Common Equity	45Cr	50Cr	46Cr	40Cr	40Cr
Minority Interest	1.12Cr	2.02Cr	19.5L	7L	-2L
Total Equity	46Cr	52Cr	46Cr	40Cr	40Cr
Total Liabilities And Equity	69Cr	96Cr	79Cr	76Cr	69Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.51Cr	4.56Cr	4.56Cr	4.72Cr	5.47Cr
ECS Total Common Shares Outstanding	4.51Cr	4.56Cr	4.56Cr	4.72Cr	5.47Cr
Book Value / Share	9.93	11	9.99	8.42	7.25
Tangible Book Value	19Cr	22Cr	23Cr	17Cr	18Cr
Tangible Book Value Per Share	4.21	4.76	5.14	3.65	3.24
Total Debt	11Cr	26Cr	20Cr	21Cr	18Cr
Net Debt	-8.76Cr	2.24Cr	9.44Cr	13Cr	14Cr
Debt Equivalent Oper. Leases	2.06Cr	79.04L	1.06Cr	92.16L	62.48L
Minority Interest, Total (Incl. Fin. Div)	1.12Cr	2.02Cr	19.5L	7L	-2L
Equity Method Investments, Total	-	2Cr	-	-	9L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Work In Process, Total	2.31Cr	7Cr	4.5Cr	5.76Cr	8.99Cr
Inventories - Finished Goods, Total	3.93Cr	5.01Cr	6.05Cr	6.27Cr	1.81Cr
Buildings, Total	5.88Cr	7.01Cr	7.82Cr	9.13Cr	10Cr
Machinery, Total	1.21Cr	2.24Cr	2.34Cr	2.48Cr	2.8Cr
Full Time Employees	350	370	270	320	285
Accumulated Allowance for Doubtful Accounts (Supple)	9L	9L	51.85L	77.5L	69.78L

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Net Income	46.92L	4.48Cr	-6.2Cr	-6.78Cr	-3.57Cr
Depreciation & Amortization - CF	73.93L	1.17Cr	1.32Cr	1.54Cr	1.71Cr
Depreciation & Amortization, Total	73.93L	1.17Cr	1.32Cr	1.54Cr	1.71Cr
(Gain) Loss From Sale Of Asset	-	-	4L	-9L	32.66L
(Gain) Loss on Sale of Investments - (CF)	18.68L	2L	7L	-4L	21.49L
Asset Writedown & Restructuring Costs	-	-	6.77Cr	-	-
Provision for Credit Losses	-	-	23.3L	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	64.52L	89.07L	25.92L	22.81L	24.29L
Other Operating Activities, Total	62.69L	-1.13Cr	1.26Cr	-62.88L	86.8L
Change In Accounts Receivable	83.9L	-1.83Cr	-2.35Cr	84.27L	3.08Cr
Change In Inventories	-1.55Cr	-7.52Cr	3.47Cr	-1.32Cr	1.1Cr
Change In Accounts Payable	27.87L	5.7Cr	-4.76Cr	-89L	-88.16L
Change in Other Net Operating Assets	26.44L	3.34Cr	-5.47Cr	45.18L	-1.41Cr
Cash from Operations	2.5Cr	5.13Cr	-5.36Cr	-6.69Cr	1.68Cr
Capital Expenditure	-1.4Cr	-1.97Cr	-26.19L	-43.76L	-35.49L
Sale of Property, Plant, and Equipment	-	-	25T	-	-
Cash Acquisitions	-1.91Cr	-1.45Cr	-42L	11.08L	-1L
Divestitures	-	-	-	-3L	24.3L
Sale (Purchase) of Intangible assets	-	-	-	-4L	-
Investment in Marketable and Equity Securities, Total	-12.46L	-	-	-	-7L
Net (Increase) Decrease in Loans Originated / Sold - Investing	-73.42L	-9.52Cr	61.32L	1.31Cr	-3L
Other Investing Activities, Total	-2.35Cr	-1.3Cr	54.35L	85.88L	2L
Cash from Investing	-6.52Cr	-14Cr	47.73L	1.77Cr	-19.91L
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	7.55Cr	26Cr	6.27Cr	19Cr	2.12Cr
Total Debt Issued	7.55Cr	26Cr	6.27Cr	19Cr	2.12Cr
Long-Term Debt Repaid, Total	-96.3L	-13Cr	-12Cr	-18Cr	-5.03Cr
Total Debt Repaid	-96.3L	-13Cr	-12Cr	-18Cr	-5.03Cr
Issuance of Common Stock	14Cr	-	-	3.4Cr	15L
Other Financing Activities, Total	1T	-1.73Cr	-2.09Cr	-1.53Cr	-1.9Cr
Cash from Financing	20Cr	12Cr	-8.29Cr	2.65Cr	-4.67Cr
Foreign Exchange Rate Adjustments	-45.36L	71.56L	3L	-39T	-44T
Miscellaneous Cash Flow Adjustments	-1T	-	-	-	-
Net Change in Cash	16Cr	3.64Cr	-13Cr	-2.28Cr	-3.19Cr
Supplemental Items
Cash Interest Paid	51.16L	1.73Cr	2.09Cr	1.52Cr	1.9Cr
Cash Income Tax Paid (Refund)	1.18Cr	79.71L	76.11L	1.29Cr	-3L
Levered Free Cash Flow	72.75L	-4.67Cr	-5.83Cr	-3.12Cr	-3.74Cr
Unlevered Free Cash Flow	75.36L	-4.63Cr	-5.79Cr	-1.83Cr	-2.51Cr
Change In Net Working Capital	1.13Cr	7.27Cr	7.01Cr	-2.38Cr	-9L
Net Debt Issued / Repaid	6.58Cr	14Cr	-6.2Cr	77.43L	-2.91Cr

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Profitability
Return on Assets	3.75	3.09	-0.11	-7.09	-5.78
Return on Total Capital	4.39	3.77	-0.13	-8.71	-7.07
Return On Equity %	1.94	8.83	-12.99	-17.03	-9.27
Return on Common Equity	1.3	9.44	-12.96	-15.91	-9
Margin Analysis
Gross Profit Margin %	46.69	44.25	30.54	17.61	15.06
SG&A Margin	22.95	23.83	26.97	45.17	34.57
EBITDA Margin %	16.17	12.44	1.88	-32.75	-20.48
EBITA Margin %	13.84	10.51	-0.42	-36.8	-24.89
EBIT Margin %	13.84	10.51	-0.42	-36.8	-24.89
Income From Continuing Operations Margin %	3.32	11.26	-17.87	-30.48	-13.61
Net Income Margin %	2.14	11.53	-17.43	-28.38	-13.22
Net Avail. For Common Margin %	2.14	11.53	-17.43	-28.38	-13.22
Normalized Net Income Margin	4.78	5.75	-3.29	-26.17	-18.99
Levered Free Cash Flow Margin	3.31	-12.02	-16.41	-13.06	-13.85
Unlevered Free Cash Flow Margin	3.43	-11.92	-16.28	-7.66	-9.31
Asset Turnover
Asset Turnover	0.43	0.47	0.41	0.31	0.37
Fixed Assets Turnover	3.14	4.1	3.54	2.36	2.6
Receivables Turnover (Average Receivables)	14.15	13.1	6.98	4.21	7.28
Inventory Turnover (Average Inventory)	2.88	2.38	2.01	1.74	2.01
Short Term Liquidity
Current Ratio	1.74	1.62	1.85	1.73	1.48
Quick Ratio	1.19	0.95	1.03	0.96	0.91
Operating Cash Flow to Current Liabilities	0.13	0.16	-0.24	-0.3	0.08
Days Sales Outstanding (Average Receivables)	25.8	27.87	52.29	87.02	50.14
Days Outstanding Inventory (Average Inventory)	126.79	153.67	181.5	209.95	181.56
Average Days Payable Outstanding	94.56	126.68	175.81	134.88	122.41
Cash Conversion Cycle (Average Days)	58.04	54.86	57.99	162.09	109.29
Long Term Solvency
Total Debt/Equity	23.72	48.93	42.81	53.16	46.17
Total Debt / Total Capital	19.17	32.85	29.98	34.71	31.59
LT Debt/Equity	7.26	23.55	22.5	34.5	19.92
Long-Term Debt / Total Capital	5.87	15.81	15.76	22.52	13.63
Total Liabilities / Total Assets	33.09	45.57	41.9	47.85	42.6
EBIT / Interest Expense	72.75	64.85	-2.07	-4.26	-3.42
EBITDA / Interest Expense	90.44	83.42	16.06	-3.51	-2.55
(EBITDA - Capex) / Interest Expense	56.88	52.08	12.46	-3.72	-2.73
Total Debt / EBITDA	2.88	4.86	16.78	-2.92	-3.65
Net Debt / EBITDA	-2.32	0.43	8.09	-1.83	-2.72
Total Debt / (EBITDA - Capex)	4.58	7.78	21.64	-2.75	-3.41
Net Debt / (EBITDA - Capex)	-3.69	0.68	10.43	-1.73	-2.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	237.78	76.93	-8.52	-32.82	13.13
Gross Profit, 1 Yr. Growth %	205.36	67.71	-36.86	-61.28	-3.21
EBITDA, 1 Yr. Growth %	2.39T	36.06	-86.18	-1.04T	-29.25
EBITA, 1 Yr. Growth %	-2.62T	34.35	-103.68	-83.8T	-23.49
EBIT, 1 Yr. Growth %	-2.62T	34.35	-103.68	-83.8T	-23.49
Earnings From Cont. Operations, 1 Yr. Growth %	-120.24	499.88	-245.22	14.58	-49.47
Net Income, 1 Yr. Growth %	-112.6	855.63	-238.24	9.42	-47.33
Normalized Net Income, 1 Yr. Growth %	-656.39	113.07	-152.27	485.02	-17.92
Diluted EPS Before Extra, 1 Yr. Growth %	-106.82	798.39	-237.62	8.82	-55.1
Accounts Receivable, 1 Yr. Growth %	49.16	119.21	49.96	-14.18	-58.47
Inventory, 1 Yr. Growth %	227.12	92.79	-24.74	14.07	-10.22
Net Property, Plant and Equip., 1 Yr. Growth %	61.79	19.22	-5.49	7.97	-2.31
Total Assets, 1 Yr. Growth %	110.35	37.54	-17.89	-3.06	-9.44
Tangible Book Value, 1 Yr. Growth %	125.06	20.8	7.79	-26.35	2.87
Common Equity, 1 Yr. Growth %	63.21	11.89	-9.21	-12.78	-0.11
Cash From Operations, 1 Yr. Growth %	220.65	70.12	-204.61	24.79	-125.16
Capital Expenditures, 1 Yr. Growth %	-32.69	40.73	-86.73	67.09	-18.9
Levered Free Cash Flow, 1 Yr. Growth %	-156.3	-742.36	-12.57	-56.7	20.02
Unlevered Free Cash Flow, 1 Yr. Growth %	-159.07	-714.87	-12.74	-67.86	37.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	396.09	144.47	27.22	-21.61	-12.83
Gross Profit, 2 Yr. CAGR %	374.99	126.3	2.9	-50.56	-38.78
EBITDA, 2 Yr. CAGR %	-34.2	385.81	-57.76	22.73	104.21
EBITA, 2 Yr. CAGR %	-39.43	482.27	-77.64	47.81	2.43T
EBIT, 2 Yr. CAGR %	-39.43	482.27	-77.64	47.81	2.43T
Earnings From Cont. Operations, 2 Yr. CAGR %	11.26	10.18	195.15	28.99	-23.91
Net Income, 2 Yr. CAGR %	-10.77	9.72	263.47	22.99	-24.08
Normalized Net Income, 2 Yr. CAGR %	-55.9	244.29	6.67	68.66	119.13
Diluted EPS Before Extra, 2 Yr. CAGR %	-37.12	-17.9	251.62	22.38	-30.1
Accounts Receivable, 2 Yr. CAGR %	242.29	80.82	81.31	13.44	-40.3
Inventory, 2 Yr. CAGR %	266.27	151.13	30.1	-7.34	1.2
Net Property, Plant and Equip., 2 Yr. CAGR %	64.04	38.88	6.15	1.02	2.7
Total Assets, 2 Yr. CAGR %	55.94	71.35	6.27	-10.78	-6.3
Tangible Book Value, 2 Yr. CAGR %	46.92	60.39	14.11	-10.9	-12.95
Common Equity, 2 Yr. CAGR %	32.3	35.14	0.79	-11.01	-6.66
Cash From Operations, 2 Yr. CAGR %	47.06	154.81	33.41	14.26	-43.96
Capital Expenditures, 2 Yr. CAGR %	-29.4	-2.67	-56.79	-52.92	16.41
Levered Free Cash Flow, 2 Yr. CAGR %	-40.17	90.17	187.62	-35.9	-27.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-37.3	90.59	181.33	-47.66	-33.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	251.81	76.16	2.83	-11.41
Gross Profit, 3 Yr. CAGR %	-	235.72	47.87	-25.71	-38.15
EBITDA, 3 Yr. CAGR %	51.96	-16.17	48.31	27.83	2.15
EBITA, 3 Yr. CAGR %	44.24	-21.01	7.64	43	18.68
EBIT, 3 Yr. CAGR %	44.24	-21.01	7.64	43	18.68
Earnings From Cont. Operations, 3 Yr. CAGR %	-17.09	95.08	20.8	115.31	-5.62
Net Income, 3 Yr. CAGR %	-28.43	96.66	18.5	143.6	-7.29
Normalized Net Income, 3 Yr. CAGR %	11.18	-25.45	83.67	82.56	32.66
Diluted EPS Before Extra, 3 Yr. CAGR %	-48.03	57.5	-2.47	137.84	-12.39
Accounts Receivable, 3 Yr. CAGR %	-	195.04	69.89	41.3	-18.85
Inventory, 3 Yr. CAGR %	-	195.73	76.91	24.52	-8.31
Net Property, Plant and Equip., 3 Yr. CAGR %	901.97	47.48	22.16	6.75	-0.1
Total Assets, 3 Yr. CAGR %	167.34	50.29	34.09	3.06	-10.34
Tangible Book Value, 3 Yr. CAGR %	112.98	35.12	40.49	-1.38	-6.53
Common Equity, 3 Yr. CAGR %	183.5	25.11	18.36	-3.95	-7.52
Cash From Operations, 3 Yr. CAGR %	156.3	64.25	89.38	30.47	-31
Capital Expenditures, 3 Yr. CAGR %	432.33	-11.15	-49.91	-32.18	-43.56
Levered Free Cash Flow, 3 Yr. CAGR %	40.04	32	65.28	64.14	-21
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.82	34.21	65.56	35.72	-27.77
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	92.97	32.96
Gross Profit, 5 Yr. CAGR %	-	-	-	56.04	3.92
EBITDA, 5 Yr. CAGR %	-	111.39	-7.98	-0.95	93.35
EBITA, 5 Yr. CAGR %	98.82	104.26	-31.73	1.18	123.53
EBIT, 5 Yr. CAGR %	98.82	104.26	-31.73	1.18	123.53
Earnings From Cont. Operations, 5 Yr. CAGR %	96.19	51.28	37.78	65.33	0.41
Net Income, 5 Yr. CAGR %	79.61	52.02	37.09	62.99	-0.83
Normalized Net Income, 5 Yr. CAGR %	68.54	71.67	8.88	2.98	93.59
Diluted EPS Before Extra, 5 Yr. CAGR %	41.23	24.6	13.8	42.38	-14.64
Accounts Receivable, 5 Yr. CAGR %	-	-	-	101.3	11.81
Inventory, 5 Yr. CAGR %	-	-	-	91.72	41.49
Net Property, Plant and Equip., 5 Yr. CAGR %	545.86	662.55	308.2	26.77	13.97
Total Assets, 5 Yr. CAGR %	89.96	107.1	85.39	21.99	16.18
Tangible Book Value, 5 Yr. CAGR %	51.15	58.48	64.11	14.39	16.01
Common Equity, 5 Yr. CAGR %	79.44	87.35	87.46	9.17	7.63
Cash From Operations, 5 Yr. CAGR %	86.46	121.3	104.87	42.06	16.36
Capital Expenditures, 5 Yr. CAGR %	357.49	-	94.95	-31.08	-29.82
Levered Free Cash Flow, 5 Yr. CAGR %	117.83	86.57	85.6	8.95	23.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	139.29	94.92	77.45	-0.94	14.53